Formosa Pharmaceuticals, Inc.’s Post

Here's a sneak peek of Dr.Iqbal Afridi's speech at the Avson Launch hosted by Swiss Pharmaceuticals Ltd.! He highlights the advanced technology in the New Avson, designed to prevent internal bleeding, a common concern with older formulas. #Swisspharma #AvsonLaunch #guestspeaker #AdvancedHealthcare #InnovationInMedicine

#BiosharesBiotechSummit Jon Pilcher kicks off a session on “New Opportunities” with reflections on Neuren Pharmaceuticals Limited’s existing approved drug DAYBUE and the next one in the pipeline, NNZ-2591: 📉 a long road to significant economic benefit for the company, including a significant market price drop when their deal with Acadia was initially announced 🤝the importance of putting in the groundwork with physicians, families and payers 📈 with revenue starting to flow from the DAYBUE deal with Acadia, the company has had the bandwidth to carefully plan the programs for NNZ-2591 🎯 thoughts on the competitive landscape, directing the company to target the indications with no known competing programs 🔀 executing “plan A” and keeping options open for partnering / M & A

Even when challenged by public scrutiny and controversies, the pharmaceutical industry stands firm with one goal—to help extend and enhance lives. Among the many achievements that this industry has contributed to is the increasing life expectancy, now nearing 80 years. And today’s seniors live healthier lives than before. Know more about this topic by reading the blog here: https://buff.ly/3QMs8H4 #LifeExpectancyAndHealth #PharmaceuticalAdvancement

Xbrane Biopharma and Intas enter into global license and co-development agreement for Nivolumab biosimilar. The Nivolumab biosimilar will be commercialized by Intas, through its subsidiary Accord Healthcare.

Omar Syan: On a #Mission to Make #Hawkary the Middle Eastern #Pharma Sector’s #Crown Jewel In the post-pandemic era of modern #healthcare, we need leaders who consider healthcare, medicines, and pharmaceutical industries from a humane perspective rather than a purely capital perspective. This is where Omar Syan, Chief Executive Officer of #Hawkary Pharmaceuticals., shines like a star. For further details, please refer to the link below. https://lnkd.in/dDuWaWJG #hawkary #CEO #Pharma #ciolook

Check the video below unveiling the insightful mission of Hawkary Pharmaceuticals presented by our CEO and my direct manager: Mr. Omar Syan, after being featured on the cover of the American magazine CIOLook as one of the most dynamic visionary leaders in the Middle East.

👏 🚀 Congrats to our participating company Hyloris Pharmaceuticals, which has just published its very positive results for 2023. Its innovative new drug, the analgesic Maxigesic IV, will form the cornerstone of the company's development in the coming years. 💊 This new drug has already received approval from the US FDA. And there's more to come: imminent launches are planned in several other countries, bringing the total number of countries where Maxigesic IV will be available to over 30. stijn van rompay's teams are doing a fantastic job, which naturally continues in research and development on other themes. 🧪With 18 reformulated and redesigned molecules, and 3 high-barrier generics, several clinical trials should begin or be completed between now and 2024. The company is accelerating the growth of its product portfolio, aiming to reach 30 candidate proposals by 2025. The adventure continues in the best possible way! Read the article in L'Echo. The link is in the comments of this post! 👇 A lifesciences project? Get in touch with us. Our contact details are also in the comment section of this post. 👇 #lifesciences #pharma #medecine #innovation Gery Lefebvre Anne VEREECKE

Even when challenged by public scrutiny and controversies, the pharmaceutical industry stands firm with one goal—to help extend and enhance lives. Among the many achievements that this industry has contributed to is the increasing life expectancy, now nearing 80 years. And today’s seniors live healthier lives than before. Know more about this topic by reading the blog here: https://bit.ly/3yvaH7y #LifeExpectancyAndHealth #PharmaceuticalAdvancement

“ Join us as we unravel the secrets of the Pharmacy Industry! Dive deep into the world of pharmaceuticals with Prof. (Dr.) P. K. Rajput, Senior VP at Cadila Pharmaceuticals. Mark your calendars for May 2nd at 11:00 am and head to M.L. Schroff (Seminar) Hall, SRCP, Banmore for an enlightening Expert Q&A session. Don’t miss out! For inquiries, contact Mr. Rohit Batra at +91-7899296319. #PharmaInsights #ExpertQnA #SRCPBanmore”

📊 Acurx Pharmaceuticals, Inc. Q2 2024 Results & Business Update Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP). has released its second quarter 2024 results, along with key updates on our business progress and future plans. 💊✨ Tap the link for the article👇🏻👇🏻👇🏻 https://lnkd.in/e4VUPnD6 #acurxpharmaceuticals #wellness #health #healthcare #cure #medicine #pharmacy #science #businessupdate #businessnews #business #news #newtothestreet